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Objective: To describe the clinical manifestation of patient with severe dengue, to
identify the serotypes and genotypes of dengue viruses (DENV) which concurrently
infecting the patient, and to explore the possible relationship of severe dengue with the
concurrent infection of DENV.
Methods: Dengue diagnosis was performed using NS1 antigen detection and IgG/IgM
ELISA. Standard clinical and laboratory examinations were performed to obtain the
clinical and hematological data. DENV concurrent infections were detected and
conﬁrmed using RT-PCR and DENV Envelope gene sequencing. Phylogenetic analyses
were performed to determine the genotypes of the viruses.
Results: The patient was classiﬁed as having severe dengue characterized by severe
plasma leakage, hemorrhage, and organ damage involving lung, liver, and kidney.
Concurrent infection of DENV serotype 2 and 3 was observed. The infecting DENV-2
virus was grouped into Cosmopolitan genotype while DENV-3 virus was classiﬁed
into Genotype I. Both viruses were closely related to isolates that were endemic in
Jakarta. Viremia measurement was conducted and revealed a signiﬁcantly higher virus
titer of DENV-3 compared to DENV-2.
Conclusions: The occurrence of multi-serotype DENV infections was presented in a
patient with severe clinical manifestation in Indonesia. The hyperendemicity of dengue in
Indonesia may contribute to the DENV concurrent infections cases and may underlie the
severity of the disease.1. Introduction
Dengue is currently one of the most important arboviral
disease in the world [1]. The disease is caused by infection of
dengue virus (DENV), which is transmitted to human through
the bites of Aedes spp. mosquito vectors. DENV consisted of
four antigenically distinct but genetically similar serotypes,
which are designated as DENV-1, DENV-2, DENV-3 andDENV-4 [2]. Dengue clinical manifestations vary from
asymptomatic or mild ﬂu-like syndrome known as classic
dengue fever to more severe form known as dengue hemorrhagic
fever (DHF) and the potentially fatal Dengue shock syndrome
[3].
Dengue regularly occurred in tropical and sub-tropical re-
gions around the world [4]. Co-circulation of multiple DENV
serotypes is considered as one of the factors contributing to high
cases of dengue infection. The circulation of multiple DENV
serotypes in the same area has been reported since decades ago
in countries in South East Asia, Central America, and South
America [1]. In 2011, the entire tropical world is hyperendemic
with multiple virus serotypes co-circulating in most large
urban centers [1]. Indonesia is a tropical country that isrticle under the CC BY-NC-ND license (http://
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circulating in the region. Dengue has become major public
health problem in the country since it was ﬁrst discovered in
1968 in Surabaya [5] and currently, the disease occurred in all
34 provinces in Indonesia [6]. Dengue cases occurred
throughout the year and outbreaks occurred periodically such
as those in 1998 [7] and 2004 [8].
Concurrent infections by more than one DENV serotypes
have been suggested to inﬂuence clinical manifestation, and this
was considered as one of the explanations for the emergence of
DHF [9]. Living in dengue hyperendemic region, people in
Indonesia have high probabilities of having concurrent DENV
infections which may lead to severe dengue. Concurrent
infections of DENV in Indonesia were ﬁrst documented during
1975–1978 epidemics [10]. And then, more recent cases were
also reported [11]. In this study, we reported a concurrent
DENV-2 and DENV-3 infection case in patient with severe
dengue. We examined the clinical, diagnostic, virological and
molecular aspects of this DENV concurrent infections case.
2. Materials and methods
2.1. Case report, sample collection and serological tests
A 38-years old female patient (ID JKT-AD001) was
administered to Gatot Soebroto Central Army Hospital in
Jakarta, Indonesia on 16 April 2013. Serum sample was
collected at day ﬁve of fever and routine diagnosis for conﬁr-
mation of dengue infection was performed. Written informed
consent was obtained from the patient. Serology and DENV
NS1 antigen detection were performed using the Panbio NS1
rapid test and IgG/IgM ELISA (Alere, Brisbane, Australia). The
IgG/IgM ELISA results were used to determine primary versus
secondary dengue infection, according to manufacturer's proto-
col. Brieﬂy, primary dengue infection was indicated by positive
IgM (>11 Panbio Units) and negative IgG (<22 Panbio Units)
while secondary dengue infection was indicated by positive IgG
(>22 Panbio Units), which may be accompanied by elevated
IgM levels.
2.2. RNA extraction, DENV detection and serotyping
Strict controls were applied on RNA extraction and PCR
preparation/reaction procedures to prevent cross-contamination
between samples. All of activities were performed in separate
areas/containments and using separate sets of equipment con-
ducted within Good Clinical Laboratory Practice-certiﬁed labo-
ratory at the Eijkman Institute. DENV genomic RNA was
extracted from 140 mL of patient's serum using QIAamp Viral
RNA Mini kit (Qiagen, Hilden, Germany). DENV nucleic acid
detection and serotyping were performed using two steps con-
ventional RT-PCR according to protocol described by Lanciotti
et al. [12], with modiﬁcation according to Harris et al. [13].
Superscript III RT enzyme (Invitrogen-Life Technologies,
Carlsbad, CA) was used in the reverse-transcription reaction.
The resulting cDNA was used in subsequent PCR reactions
using Taq DNA Polymerase (Roche, Mannheim, Germany).
2.3. Determination of viral load
Two steps quantitative RT-PCR (qRT-PCR) analysis was
used to quantify the virus titer in serum according to protocoladapted from conventional RT-PCR method by Lanciotti et al.
[12]. Extracted RNA was reverse-transcribed using D2 antisense
primer. The resulting cDNA was used as template in qRT-PCR
reaction performed using Power SYBR-Green PCR kit and
7500 RT-PCR System (Applied Biosystems-Life Technologies,
Foster City, CA). Viral load determination was performed in
separate reaction mixes using serotype-speciﬁc primers D1 and
TS2 and D1 and TS3 for DENV-2 and DENV-3, respectively.
The reaction was prepared in triplicate using 400 nM of primers
ﬁnal concentration and thermal cycling setup of 10 min initial
denaturation step at 95 C, followed by 35 cycles of 10 s
denaturation step at 95 C and 1 min annealing/extension step at
60 C. An additional dissociation stage was used to verify the
melting temperature of amplicons. A recombinant plasmid
standard was generated by cloning DENV genome fragment
covering the C, prM/M, and Envelope (E) genes into PCR-Blunt
plasmid using Zero Blunt PCR Cloning Kit (Invitrogen-Life
Technologies) according to the manufacturer's instructions.
Known copy number of recombinant plasmid was serially
diluted and used as genome copy number standards in RT-PCR
analyses. The copy number standards were then used to quan-
tify genome copy number of viral RNA transcripts from 10-fold
dilutions of known DENV titer measured by plaque assay in
BHK21 cells. The resulting copy number-titer equivalent stan-
dard curve was used to calculate viral load in sample deter-
mined as DENV plaque forming unit (PFU) equivalent/mL of
serum.
2.4. DENV Envelope gene sequencing
Viral RNA was extracted directly from serum sample and
used as template for DENV genotyping using E gene sequences
according to protocol described previously in Ref. [11]. Capillary
sequencing reactions were performed to obtain complete E gene
sequences of DENV-2 (1485 nt) and DENV-3 (1479 nt),
employing serotype-speciﬁc primers described elsewhere [14]. In
order to prevent possible contamination from DENV reference
strains/positive controls being used, we have performed E
gene sequencing for all of the reference strains available in
our laboratory and maintained a controlled virus archiving
procedure. The E gene sequences obtained in this study have
been deposited in GenBank with accession numbers KJ184316
(for isolate JKT-AD001A) and KJ184317 (for isolate JKT-
AD001B).
2.5. DENV genotype analyses
DENV genotype analyses were performed to generate clas-
siﬁcation of isolate sequences into genotypes. Isolate sequences
were combined with the downloaded GenBank sequences ac-
cording to sample's serotypes to create dataset for each geno-
types grouping based on Twiddy [15] and Lanciotti [16]
classiﬁcations for DENV-2, and DENV-3, respectively. Multi-
ple sequence alignment for E gene was performed using
MUSCLE [17]. Dataset for each serotype was prepared using
BEAUti v.1.7.5 [18] and followed by phylogenetic
reconstruction analysis using Bayesian Markov chain Monte
Carlo method as implemented in BEAST v 1.7.5 [19] using
GTR + G4 model with codon model, relaxed uncorrelated
lognormal molecular clock and Bayesian skyline prior, with
100 million generations and sampled for every 1000th
iteration. All parameters showed effective sampling size values
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credibility (MCC) tree was created using TreeAnnotator
v.1.7.5 and visualized in FigTree v.1.4.0, which are available
inside the BEAST package.
3. Results
3.1. Clinical manifestation
A 38-year old female patient was administered to Gatot
Soebroto Central Army Hospital in Jakarta, Indonesia after
experiencing four days fever accompanied with myalgia,
arthralgia, headache, vomiting, skin rash, epistaxis, and gum
bleeding. Initial physical examination on the ﬁrst day of hos-
pitalization observed a normotensive blood pressure with
38.6 C fever. Patient was fully conscious but presented a
shortness of breath and bleeding gums. Lung examination
presented smooth wet rhonchi, whereas the abdominal exam-
ination showed epigastric tenderness but no hepatomegaly
observed. Petechiae were observed in both arms. Chest X-ray
showed dextral pleural effusion. Normal electrocardiography
was observed. Patient was diagnosed as DHF Grade III based
on high fever with headache, myalgia, arthralgia, vomiting,
abdominal pain, appetite loss, epistaxis and bleeding gums,
wet rhonchi, mid-epigastric pain, petechiae and evidence of
plasma leakage which include pleural effusion and hypo-
proteinemia. Thrombocytopenia and elevated level of trans-
aminase enzymes were observed, however, hematocrit was still
within normal level during acute phase. The patient condition
on day ﬁve of hospitalization was worsened and then moved to
ICU.
Further development in ICU, the patient showed stable vital
signs and better breathiness. No fever, headache, abdominal
pain, epistaxis and bleeding gums were observed. Appetite was
gradually increased and nausea was absence. Vaginal bleeding
was decreasing. At the tenth day of treatment in the ICU, a stable
vital sign was observed and the patient was free of fever for
approximately 3 d. Shortness of breath and hemorrhagic mani-
festations were not observed, although physical examination
observed extensive hematoma in the arm region around the
venipuncture area.Table 1
Clinical laboratory ﬁndings of patient with concurrent DENV in
Laboratory test Value
Acute
Blood count
Leukocyte 22300.0/mL
Thrombocytes 13000.0/mL
Hematocrit 25.0%
Hemoglobin 9.4 g/dL
APTT 2.3 × control
Biochemistry
SGOT 5641.0 U/L
SGPT 1807.0 U/L
Sodium 131.0 mmol/L
Potassium 3.4 mmol/L
Albumin 2.6 g/dL
Urea 21.0 mg/dL
Creatinine 0.8 mg/dL
APTT: Activated partial thromboplastin time.
Acute phase was described as the day of hospitalization (day 0),3.2. Clinical laboratory ﬁndings
Laboratory examination observed severe thrombocytopenia
(13000/mL) during febrile period, while ﬁnal platelet count of
156000/mL was observed when the patient has been fully
recovered (convalescence phase at d 15 after hospitalization)
(Table 1). Although thrombocytopenia was prominent in this
patient, no signiﬁcant hematocrit increment was observed during
the course of hospitalization, although slight increase was
observed during convalescence. The transaminase enzymes
levels, markers for the liver function, showed gradual increment
with the maximum level for SGOT/SGPT reached 5 641/
1 807 IU/L. When the patient was fully recovered, the ﬁnal
levels of 82/134 IU/L were observed (Table 1). Leukocytosis
was observed, with a maximum count of 22300/mL. Leukocy-
tosis was then improved to 8000/mL at convalescence period
(Table 1). We also examined the electrolyte level in the patient,
in which hyponatremia, hypocalcemia, and hypoalbuminemia
were observed (Table 1). Improvements of the above hemato-
logical ﬁndings were observed when patient in convalescence
period. A sterile blood culture results was obtained. Chest X-ray
result consistent with a sign of pneumonia. Patient was fully
recovered.
3.3. Disease complication
We observed disease complications that may have effect to
the clinical ﬁndings. Pulmonologist consultant observed the
pulmonary edema with bronchopneumonia, and hemoptysis.
The patient has a history of tuberculosis, and secondary bacterial
infection was proposed based on fever, asphyxia, and coughing
with white phlegm. Obstetrician diagnosed the patient with
abnormal uterus bleeding caused by endometrium hyperplasia
that had occurred within the last two months. This was
conﬁrmed by USG examination.
3.4. DENV serology, RT-PCR, and viral load
determination
Patient serum collected on day ﬁve of fever was tested pos-
itive by anti-dengue NS1 Rapid Test. The anti-dengue IgM andfections.
Reference value
Convalescence
8000.0/mL 4500.0–10000.0/mL
156000.0/mL 130000.0–340000.0/mL
41.0% 35.0%–50.0%
10.6 g/dL 12.1–15.1 g/dL
1.6 × control Laboratory control
82.0 U/L 5.0–40.0 U/L
134.0 U/L 7.0–56.0 U/L
138.0 mmol/L 134.0–145.0 mmol/L
3.4 mmol/L 3.4–5.2 mmol/L
3.4 g/dL 3.5–5.3 mg/dL
67.0 mg/dL 15.0–45.0 mg/dL
1.5 mg/dL <1.4 mg/dL
while convalescence phase was d 15 after hospitalization.
Figure 2. MCC tree of DENV-2 genotypes grouping generated by Bayesian in
gamma parameter rates from the E gene sequences.
The Jakarta JKT-AD001A isolate (denoted with red label) was grouped into th
from Indonesian cities were denoted with blue labels. The number in the node
Figure 1. (A) Detection of DENV concurrent infections in JKT-AD001
patient's serum using conventional RT-PCR.
M: DNA molecular weight marker; lane 1: no-template control; lane 2–5:
PCR amplicon positive controls for DENV-1 (strain WestPac), DENV-2
(strain NGC), DENV-3 (strain H87), and DENV-4 (strain H241) respec-
tively; lane 6: PCR amplicons for patient serum.
(B) Conﬁrmation of DENV detection and viral titer measurement using
SYBR-Green qRT-PCR.
DRn is the ﬂuorescence of the reporter dye divided by ﬂuorescence of a
passive reference dye, minus the baseline. Virus titers are depicted in the
table below the RT-PCR ampliﬁcation plot.
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positive (data not shown). The infection status of the patient was
secondary infection as determined by the IgM and IgG values,
performed according to the assay method. Conﬁrmation of
DENV infection was further pursued using RT-PCR to detect
and serotype the infecting virus. The RT-PCR detected the
presence of two PCR amplicons which were corresponded to
DENV-2 and DENV-3, albeit of fainter band for DENV-2
(Figure 1A). To quantitatively determine the titers of the
infecting viruses, we performed qRT-PCR detection of viremia
in the patient's serum. The presence of concurrent infections was
further conﬁrmed using this method (Figure 1B), and the
DENV-2 virus titer was determined as 2.5 × 102 PFU equiva-
lent/mL of serum, while DENV-3 viral load reached
6.8 × 104 PFU equivalent/mL (Figure 1B).
3.5. DENV E gene sequencing and phylogenetic analysis
Given the presence of two DENV serotypes in RT-PCR
detection and serotyping result, we sought to further conﬁrm
the concurrent DENV infections by using E gene sequencing.
Ampliﬁcation of E gene in RNA directly extracted from serum
sample successfully obtained both DENV-2 and DENV-3 E
gene amplicons (data not shown). The E gene fragments were
then subjected to DNA sequencing. The sequences of the E
genes conﬁrmed the serotypes of the infecting viruses as DENV-
2 and DENV-3. To determine the genotype of the viruses, we
performed phylogenetic analyses of both DENVs. Our phylo-
genetic analysis of DENV-2 grouped the infecting virus into
Cosmopolitan genotype according to Twiddy et al [15]
(Figure 2). The isolate (JKT-AD001A) was closely related to
viruses we recently isolated in Sukabumi, West Java province,
Indonesia in 2012 [20] and grouped together with isolates fromference method as implemented in BEAST using GTR evolution model and
e Cosmopolitan genotype based on classiﬁcation by Twiddy et al. Isolates
indicated the posterior probability of that particular cluster.
Figure 3. MCC tree of DENV-3 genotypes grouping generated by Bayesian inference method as implemented in BEAST using GTR evolution model and
gamma parameter rates from the E gene sequences.
The Jakarta JKT-AD001B isolate (denoted with red label) was grouped into genotype I based on classiﬁcation by Lanciotti et al. Isolates from Indonesian
cities were denoted with blue labels. The number in the node indicated the posterior probability of that particular cluster.
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2004, Semarang (isolated in 2012 [11]), and Palembang
(isolated in 1998) (Figure 2). Meanwhile, phylogenetic anal-
ysis of DENV-3 E protein gene revealed the genotype of the
infecting virus as Genotype I based on Lanciotti classiﬁcation
[16].
As seen in Figure 3, the virus isolate (JKT-AD001B) was
closely related with viruses from Jakarta (isolated in 2004),
Palembang (isolated in 1998), Bandung (isolated in 1998), and
Semarang (isolated in 2012).
4. Discussion
Dengue has become a health problem in many tropical
countries including Indonesia, in which hyperendemicity con-
tributes to the increasing dengue cases. Coupled with high
vector index, the occurrence of concurrent infections with
multiple DENV serotypes is highly possible. With the
advancement of DENV detection technologies, more and more
concurrent dengue infections cases were reported. Concurrent
infections cases have been reported in Mexico, Puerto Rico,
Taiwan, China, Brazil, Thailand, and India [10,21–28]. For
Indonesia, the concurrent infections were ﬁrst reported during
outbreaks in 1976–1978, which was accounted for 11.1% of
the cases [10]. We have also recently reported other concurrent
infections cases in Semarang city, Indonesia [11] and other
cities in Indonesia [29]. In this study, we reported a concurrent
infections case in patient from Jakarta, a city with highest
dengue incidence rate in Indonesia [6]. We believe that
concurrent infections cases may also occurred in other cities in
Indonesia. However, because of the limited data on DENV
surveillance in Indonesia, the available data may be under-reported. This study was the ﬁrst to report the concurrent in-
fections case in Indonesia in detail, in which the clinical, diag-
nostic, molecular and virological aspects of the infection were
presented.
Concurrent infections have been proposed as one of contrib-
uting factors to severe dengue [9]. However, several reports
described the absence of relationship between concurrent
infections with severe disease [10,26]. Unlike those reports, the
patient reported in this study presented a severe dengue. The
patient exhibited abdominal pain and persistent vomiting,
clinical warning signs of severe dengue [4]. Leukocytosis was
also observed, which may indicate a warning sign of severe
dengue [30]. The atypical manifestations of dengue are
uncommon, but there have been increasing reports of DF and
DHF with unusual manifestation [4,31]. In this patient, atypical
manifestations of dengue were observed and involved the
hepatic, pulmonary, and renal manifestations. It has been
reported that DHF may cause mild to moderate liver dysfunction
in most cases, however, only some patients may suffer from
acute liver failure [32]. The hepatic manifestation in this patient
was characterized by increasing level of aminotransferase
enzymes. The pulmonary involvement included shortness of
breath, pleural effusion, cough, and hemoptysis. Although renal
failure is a rare complication in dengue infections, the deranged
serum urea and creatinine levels during the course of illness in
this patient were indicative of renal dysfunction. Altogether,
these are consistent with severe dengue.
As mentioned above, although reports indicated that con-
current infections did not related with severe dengue [10,26],
other studies observed the higher percentage of cases with
concurrent infections had severe disease [25,27]. Thus, our
study is in accordance with those reports.
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associated with more severe disease [33]. In this report, we
measured the viremia using qRT-PCR. To our knowledge, our
study is the ﬁrst to present data on the viral loads of concurrent
DENV infections. We observed a signiﬁcantly higher titer of
DENV-3 (ie. 272 times) compared to the DENV-2. This data
suggest that, compared to DENV-2, the DENV-3 might
possessed better replication rate in the patient and might pre-
dominantly replicated in the body and thus affect the immune
system. However, we are not sure whether the higher viral loads
of DENV-3 compared to DENV-2 was occurred since the early
days of infection since we only measured the viral load in a
single time point (day ﬁve of fever). As far as we aware, there is
no previous study that describe the comparative ﬁtness of DENV
in patient with concurrent infections. Further, it may be that the
severity of disease in concurrent infections is not caused by the
synergistic action of both serotypes, but more likely caused by
one of the virus that have higher virus titer, just as in single
infection cases. As this study only observed the difference in
serotype-speciﬁc viral load in one patient, we cannot conﬁrm
that the ﬁnding is generalizable to other concurrent infections
cases. Determination of viral loads in larger number of con-
current infections cases will be beneﬁcial to conﬁrm this
observation.
With respect to the infecting DENV, we determined the
genotypes of both DENV-2 and DENV-3 viruses using
phylogenetic analyses based on E protein gene sequences. The
DENV-2 isolate was grouped into Cosmopolitan genotype
according to Twiddy et al. [15]. This genotype is widely
distributed in many countries such as in India, countries in
South East Asia, Africa, the Middle East, and Australia [15].
In term of genetic relationship with other DENV-2 isolates,
this isolate was closely related and grouped together with
DENV-2 viruses from Jakarta isolated in 2004, and from other
cities in Indonesia such as Sukabumi (isolated in 2012), and
Palembang (isolated in 1998). This suggested that the infecting
virus was endemic in the area, and has been circulated for a
long time. Similarly, the genotype of infecting DENV-3, which
was grouped into Genotype I according to Lanciotti et al. [16],
was closely related to DENV-3 viruses from Jakarta and other
cities in Indonesia such as Bandung, Palembang, and Semar-
ang. Altogether, our phylogenetic data demonstrated the sus-
tainable circulation of endemic strains of DENV in Indonesia
which regularly infecting people and actively transmitted in the
community.
In summary, our study presented the occurrence of multi-
serotype DENV infections in a patient with severe clinical
manifestation in Indonesia. The hyperendemicity of dengue in
Indonesia may contribute to the DENV concurrent infections
cases and may underlie the severity of the disease.
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